FG
Therapeutic Areas
Cytovation Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CY-101 | Adrenocortical Carcinoma | Phase 2 |
| CY-101 + Pembrolizumab | Colorectal Cancer | Phase 1/2 |
| Drug | Indication | Phase |
|---|---|---|
| CY-101 | Adrenocortical Carcinoma | Phase 2 |
| CY-101 + Pembrolizumab | Colorectal Cancer | Phase 1/2 |